Quality Evaluation of Anticoagulant Therapy in Patients Who Taking Warfarin in Our Hospital / 中国药房
China Pharmacy
;
(12): 2032-2034, 2016.
Artigo
em Chinês
| WPRIM
| ID: wpr-504465
ABSTRACT
OBJECTIVE:
To evaluate the quality of anticoagulant therapy in patients who took warfarin and provide data sup-porting for strengthening the management of these patients.METHODS:
A retrospective analysis of related clinical data of 214 pa-tients who meet the inclusion criteria was performed.RESULTS:
The average time for patients took warfarin was (321.64 ± 189.50)d,average times for tested INR was(12.01±7.03)times in clinic;when anticoagulant therapy,INR3.0 accounted for 8.91%;patients with target INR≤2.0 accounted for 45.33%,target INR=2.5 accounted for 38.32%,and target INR≥3.0 accounted for 0.93%;the average TTR was (50.80 ± 22.32)%;and there was no statistical significance in the TTR of different ages and diseases(P>0.05).CONCLUSIONS:
The anti-coagulant therapy in some patients who took warfarin shows poor quality,it needs strengthening the quality management to make it safe and effective.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
China Pharmacy
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS